Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabonomics and lipidomics to predict toxicity and efficacy of anti-VEGF therapy in metastatic clear cell renal cell carcinoma
2011-006085-40Phase 4Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sunitinib and pazopanib in clear cell renal cell carcinoma (ccRCC) (2 arms), sponsored by Cliniques universitaires Saint-Luc. Started Aug 2012; status: completed.
02
Drugs
sunitinibpazopanib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on 2011-006085-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006085-40.